Menopausal hormone therapy reduces risk of low bone mineral density by 69%, retrospective study finds
· Medical Xpressedited by Sadie Harley, reviewed by Andrew Zinin
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Lead Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
The GIST Add as preferred source
Women on menopausal hormone therapy face a decreased risk of low bone mineral density compared with those not using it, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
Women who do not use menopausal hormone therapy have a greater risk of developing osteopenia and osteoporosis, which can lead to fractures, disability and loss of independence.
"For years, many women have avoided menopausal hormone therapy because of safety concerns and warning labels. This study revisits that narrative and shows that menopausal hormone therapy may have an important added benefit: protecting bone health. That shifts the conversation from 'avoid if possible' to 'reconsider in the right patient,'" said Diego Espinoza-Peralta, M.D., M.Sc., vice president of the Mexican Society of Nutrition and Endocrinology (SMNE) and principal investigator at Investigación Médica Sonora (INMEDS).
The retrospective cohort study included 387 postmenopausal women who underwent DXA scans between 2021 and 2025. They were designated as menopausal hormone therapy users (33%) or nonusers (67%). Low bone mineral density was defined as osteopenia or osteoporosis.
Those taking menopausal hormone therapy had about 69% less risk of low bone mineral density in the spine and hip compared with those not using it. This finding remained even after the researchers accounted for age, time since menopause, vitamin D levels, smoking and other health conditions.
"In simple terms: menopausal hormone therapy appears to independently protect bones, not just by coincidence," Espinoza-Peralta said.
This suggests that hormone therapy could help people find relief from menopausal symptoms and prevent bone loss or lower fracture risk.
"Clinicians may begin to weigh its benefits more carefully, especially in women early after menopause, potentially improving long-term health and quality of life," Espinoza-Peralta said.
Key medical concepts
Hormone Replacement TherapyOsteoporosisBone Density, LowAbsorptiometries, DPX
Clinical categories
EndocrinologyWomen's healthObstetrics & gynecologyHealthy aging Provided by The Endocrine Society Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Menopausal hormone therapy reduces risk of low bone mineral density by 69%, retrospective study finds (2026, June 15) retrieved 15 June 2026 from https://medicalxpress.com/news/2026-06-menopausal-hormone-therapy-bone-mineral.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.